- AMGN -0.39%
Search results
- 334.30Add to watchlist-1.31 (-0.39%)At close:4:00 PM EDTThu. Jul 25, 2024338.18 +3.88 (+1.16%)Pre mkt:6:38 AM EDTFri. Jul 26, 2024Nasdaq Real Time Price (USD) · Pre-Market Time
- Open335.99High346.85Low333.02
- Mkt Cap179.33BP/E (TTM)47.83Div & Yield9.00 & 2.69%
- Prev. Close335.6152 Wk. Low228.2152 Wk. High346.85
What analysts are sayingTop storiesAmgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on ItYahoo Finance · 2 weeks ago- AMGN -0.39%
Amgen Inc.'s (NASDAQ:AMGN) high institutional ownership speaks for itself as stock continues to impress, up 6.4% over last weekYahoo Finance · 2 weeks agoRelated stocks
AMGN Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View Amgen Inc. AMGN stock quote prices, financial information, real-time forecasts, and company news from CNN.
Jul 19, 2024 · Low Forecast. $235.00. According to the 21 analysts' twelve-month price targets for Amgen, the average price target is $312.63. The highest price target for AMGN is $360.00, while the lowest price target for AMGN is $235.00. The average price target represents a forecasted downside of -6.85% from the current price of $335.61.
- (844) 978-6257
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA, 91320
- investor.relations@amgen.com
Stock Price Forecast. The 18 analysts with 12-month price forecasts for Amgen stock have an average target of 312.22, with a low estimate of 235 and a high estimate of 360. The average target predicts a decrease of -6.60% from the current stock price of 334.30.
3 days ago · Based on short-term price targets offered by 22 analysts, the average price target for Amgen comes to $316.55. The forecasts range from a low of $170.00 to a high of $380.00. The average price ...
3 days ago · Analyst Forecast. According to 20 analysts, the average rating for AMGN stock is "Buy." The 12-month stock price forecast is $312.22, which is a decrease of -6.64% from the latest price.
- 306.11-312.54
- 310.77
- 311.49
- 995,438
2 days ago · Amgen Inc. (NASDAQ:AMGN) announced its quarterly earnings results on Thursday, May, 2nd. The medical research company reported $3.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.76 by $0.20. The company's revenue for the quarter was up 22.0% compared to the same quarter last year.
People also ask
What is the average AMGN stock price target?
Should you buy Amgen stock?
Why has Amgen AMGN stock outperformed this year?
Should you buy AMGN (AMGN) stock?
3 days ago · See the latest Amgen Inc stock price (AMGN:XNAS), related news, ... like cholesterol-lowering drug Repatha defend its wide moat and keep free cash flow above 30% of sales in our forecast. ...